NEW YORK, Jan. 11, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced an agreement with Charles River Laboratories to initiate preclinical studies of HT-001, a topical formulation designed for the treatment of patients with rash and skin disorders associated with initial and repeat EGFR inhibitor… Read More..
CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure, Inc. (NASDAQ: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) technology, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designations for its clinical product candidate, cavrotolimod (AST-008), for two development programs: cavrotolimod in… Read More..
Shoop’s Leadership Experience Bridges Military, Academia, Industry and Not-for-Profit Sectors During Distinguished 40-Year Career London, UK, Jan. 07, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Bubblr Inc., (OTC PINK: BBLR), ("Bubblr" or the "Company"), an ethical technology company focused on the development and commercialization of mobile-first technologies, today announced the… Read More..